
Traditionally, risk in healthcare is confirmed after symptoms appear. But AI is changing that, identifying warning signs before doctors, or even patients, notice anything is wrong. This shift is redefining reduction, using passive data and behavioral trends to intervene earlier. Joe Kiani, Masimo and Willow Laboratories founder, built Nutu™ on this principle, that risk shows up in daily behavior, long before diagnosis. By delivering timely, context-aware nudges, it helps users act, before chronic conditions, like Type 2 diabetes, take hold.
This proactive approach empowers users to stay ahead of their health, not just react to it. By making small adjustments …


.png?width=1000&height=1000&name=CMMC%20CONSULTING%20PAGE%20(1).png)



